152 related articles for article (PubMed ID: 18649738)
1. Evaluating the function of matriptase and N-acetylglucosaminyltransferase V in prostate cancer metastasis.
Tsui KH; Chang PL; Feng TH; Chung LC; Sung HC; Juang HH
Anticancer Res; 2008; 28(4A):1993-9. PubMed ID: 18649738
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of matriptase by overexpression of bikunin attenuates cell invasion in prostate carcinoma cells.
Tsui KH; Chang PL; Feng TH; Chung LC; Hsu SY; Juang HH
Anticancer Res; 2008; 28(4A):1977-83. PubMed ID: 18649735
[TBL] [Abstract][Full Text] [Related]
3. Differential metastasis-associated gene analysis of prostate carcinoma cells derived from primary tumor and spontaneous lymphatic metastasis in nude mice with orthotopic implantation of PC-3M cells.
Chu JH; Sun ZY; Meng XL; Wu JH; He GL; Liu GM; Jiang XR
Cancer Lett; 2006 Feb; 233(1):79-88. PubMed ID: 15885894
[TBL] [Abstract][Full Text] [Related]
4. Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation.
Sanders AJ; Parr C; Martin TA; Lane J; Mason MD; Jiang WG
J Cell Physiol; 2008 Sep; 216(3):780-9. PubMed ID: 18449907
[TBL] [Abstract][Full Text] [Related]
5. Genetic reduction of matriptase-1 expression is associated with a reduction in the aggressive phenotype of prostate cancer cells in vitro and in vivo.
Sanders AJ; Parr C; Davies G; Martin TA; Lane J; Mason MD; Jiang WG
J Exp Ther Oncol; 2006; 6(1):39-48. PubMed ID: 17228523
[TBL] [Abstract][Full Text] [Related]
6. Growth differentiation factor-15 upregulates interleukin-6 to promote tumorigenesis of prostate carcinoma PC-3 cells.
Tsui KH; Chang YL; Feng TH; Chung LC; Lee TY; Chang PL; Juang HH
J Mol Endocrinol; 2012 Oct; 49(2):153-63. PubMed ID: 22872134
[TBL] [Abstract][Full Text] [Related]
7. CVS-3983, a selective matriptase inhibitor, suppresses the growth of androgen independent prostate tumor xenografts.
Galkin AV; Mullen L; Fox WD; Brown J; Duncan D; Moreno O; Madison EL; Agus DB
Prostate; 2004 Nov; 61(3):228-35. PubMed ID: 15368474
[TBL] [Abstract][Full Text] [Related]
8. Expression of core 2 beta1,6-N-acetylglucosaminyltransferase facilitates prostate cancer progression.
Hagisawa S; Ohyama C; Takahashi T; Endoh M; Moriya T; Nakayama J; Arai Y; Fukuda M
Glycobiology; 2005 Oct; 15(10):1016-24. PubMed ID: 15932919
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of prostasin serine protease: a potential invasion suppressor in prostate cancer.
Chen LM; Hodge GB; Guarda LA; Welch JL; Greenberg NM; Chai KX
Prostate; 2001 Jul; 48(2):93-103. PubMed ID: 11433419
[TBL] [Abstract][Full Text] [Related]
10. Curcumin-targeting pericellular serine protease matriptase role in suppression of prostate cancer cell invasion, tumor growth, and metastasis.
Cheng TS; Chen WC; Lin YY; Tsai CH; Liao CI; Shyu HY; Ko CJ; Tzeng SF; Huang CY; Yang PC; Hsiao PW; Lee MS
Cancer Prev Res (Phila); 2013 May; 6(5):495-505. PubMed ID: 23466486
[TBL] [Abstract][Full Text] [Related]
11. Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells.
Wu GJ; Peng Q; Fu P; Wang SW; Chiang CF; Dillehay DL; Wu MW
Gene; 2004 Mar; 327(2):201-13. PubMed ID: 14980717
[TBL] [Abstract][Full Text] [Related]
12. Co-expression of matriptase and N-acetylglucosaminyltransferase V in thyroid cancer tissues--its possible role in prolonged stability in vivo by aberrant glycosylation.
Ito Y; Akinaga A; Yamanaka K; Nakagawa T; Kondo A; Dickson RB; Lin CY; Miyauchi A; Taniguchi N; Miyoshi E
Glycobiology; 2006 May; 16(5):368-74. PubMed ID: 16464868
[TBL] [Abstract][Full Text] [Related]
13. A novel biomarker for staging human prostate adenocarcinoma: overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor-1.
Saleem M; Adhami VM; Zhong W; Longley BJ; Lin CY; Dickson RB; Reagan-Shaw S; Jarrard DF; Mukhtar H
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):217-27. PubMed ID: 16492908
[TBL] [Abstract][Full Text] [Related]
14. Prostate specific antigen gene expression in androgen insensitive prostate carcinoma subculture cell line.
Tsui KH; Feng TH; Chung LC; Chao CH; Chang PL; Juang HH
Anticancer Res; 2008; 28(4A):1969-76. PubMed ID: 18649734
[TBL] [Abstract][Full Text] [Related]
15. Expression of the prostate transglutaminase (TGase-4) in prostate cancer cells and its impact on the invasiveness of prostate cancer.
Davies G; Ablin RJ; Mason MD; Jiang WG
J Exp Ther Oncol; 2007; 6(3):257-64. PubMed ID: 17552366
[TBL] [Abstract][Full Text] [Related]
16. [Short hairpin RNA targeting N-acetylglucosaminyltransferase V inhibits the proliferation of prostate cancer PC-3 cell line].
Yao YH; Wei T; Li YH; Zhang J
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jun; 30(6):1253-5. PubMed ID: 20584650
[TBL] [Abstract][Full Text] [Related]
17. [Effect of PC-1 gene expression on migration ability of prostate cancer cells].
Zhang H; Wan LC; Wang J; Zhou JG; Huang CF
Ai Zheng; 2005 Sep; 24(9):1043-7. PubMed ID: 16159422
[TBL] [Abstract][Full Text] [Related]
18. Human prostate cancer in a clinically relevant xenograft mouse model: identification of β(1,6)-branched oligosaccharides as a marker of tumor progression.
Lange T; Ullrich S; Müller I; Nentwich MF; Stübke K; Feldhaus S; Knies C; Hellwinkel OJ; Vessella RL; Abramjuk C; Anders M; Schröder-Schwarz J; Schlomm T; Huland H; Sauter G; Schumacher U
Clin Cancer Res; 2012 Mar; 18(5):1364-73. PubMed ID: 22261809
[TBL] [Abstract][Full Text] [Related]
19. N-acetylglucosaminyltransferase V activity in metastatic models of human hepatocellular carcinoma in nude mice.
Shao DM; Wang QH; Chen C; Shen ZH; Yao M; Zhou XD; Tang ZY; Gu JX
J Exp Clin Cancer Res; 1999 Sep; 18(3):331-5. PubMed ID: 10606178
[TBL] [Abstract][Full Text] [Related]
20. PrLZ expression is associated with the progression of prostate cancer LNCaP cells.
Li L; Zhang D; Zhang L; Zhu G; Sun Y; Wu K; Wang X; He D
Mol Carcinog; 2009 May; 48(5):432-40. PubMed ID: 18800346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
